Scientists discover critical protein complex that lets virus hide from immune system

Nearly 70 graduates were accepted into residency programs of their choice in 2020

UC Riverside School of Medicine to lead engagement project in eastern Coachella Valley

Drugs previously in development for SARS could be effective for COVID-19

Brandon Brown is an associate professor in the School of Medicine at UC Riverside

NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors

Additional ongoing funding would help the medical school expand enrollment

UC Riverside research is supported by a four-year grant worth more than $1.2 million

UC Riverside-led study is the first to show how tofacitinib affects epithelial cells lining the gut

UC Riverside-led study tested the effects of microgravity on intestinal epithelial cells

UC Riverside mouse study finds early exposure to sounds can address hypersensitivity to noise associated with Fragile X Syndrome

The shape and architecture of collagen and elastin fibers can improve our understanding of lung diseases, including the one associated with vaping

UC Riverside-led research could aid regenerative stem cell therapies

UC Riverside-led open-label pilot study leads to a double-blind clinical trial to further test ecopipam’s efficacy and safety in adult patients who stutter

Five-year, $16 million grant from the National Institutes of Health will help launch Center for Health Disparities Research at UC Riverside

Research is supported by a five-year grant to UC Riverside from the National Institutes of Health

UC Riverside-led mouse study focuses on cannabis-like molecules that augment feeding behavior

School of Medicine’s Nicholas DiPatrizio will lead a team tasked with assessing the impact of long-term cannabis exposure on metabolic health and disease

Medical school graduate Hurnan Vongsachang will start her residency in emergency medicine this summer

UC Riverside biomedical scientist’s decades-long work moves to clinical trials